LinkOPH

Valeant Pharmaceuticals announced that it will acquire Synergetics USA for $6.50 per share in cash, according to a Valeant press release.“The addition of Synergetics’ portfolio of instruments and devices will further enhance Bausch + Lomb’s presence around the world in the rapidly evolving field of vitreoretinal surgery,” J. Michael Pearson, chairman and CEO of Valeant, said in the release. “We are committed to delivering a valuable and broad array of surgical devices and instruments to serve the needs of the surgical retina community and their patients.”

Read more →

With another school year here, the Internal Revenue Service reminds parents and students that now is a good time to see if they will qualify for either of two college tax credits or other education-related tax benefits when they file their 2015 federal…

Read more →

With another school year here, the Internal Revenue Service reminds parents and students that now is a good time to see if they will qualify for either of two college tax credits or other education-related tax benefits when they file their 2015 federal…

Read more →

In agreement with the FDA’s recent draft guidance on nonproprietary naming of biological products, six physician groups collectively sent a letter to CMS Acting Administrator Andrew Slavitt on Tuesday urging CMS to adopt unique billing codes for biosimilars, according to a press release. The participating organizations included the Alliance for Patient Access, American Association of Clinical Endocrinologists, American College of Rheumatology, Biologics Prescribers Collaborative, Coalition of State Rheumatology Organizations, and North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.

Read more →

In agreement with the FDA’s recent draft guidance on nonproprietary naming of biological products, six physician groups collectively sent a letter to CMS Acting Administrator Andrew Slavitt on Tuesday urging CMS to adopt unique billing codes for biosimilars, according to a press release. The participating organizations included the Alliance for Patient Access, American Association of Clinical Endocrinologists, American College of Rheumatology, Biologics Prescribers Collaborative, Coalition of State Rheumatology Organizations, and North American Society for Pediatric Gastroenterology, Hepatology and Nutrition.

Read more →

AngioPlex OCT Angiography has received 510(k) clearance from the FDA, Zeiss Medical Technology announced in a press release.This is the first OCT-angiography technology to be cleared in the U.S., Zeiss said.

Read more →